{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:21:54Z","timestamp":1761178914616,"version":"build-2065373602"},"reference-count":21,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,23]],"date-time":"2023-12-23T00:00:00Z","timestamp":1703289600000},"content-version":"vor","delay-in-days":4892,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of nutrition, health and aging"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1007\/s12603-010-0267-7","type":"journal-article","created":{"date-parts":[[2010,9,23]],"date-time":"2010-09-23T17:46:38Z","timestamp":1285263998000},"page":"553-557","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Implications of the impact survey for payors across Europe"],"prefix":"10.1016","volume":"14","author":[{"given":"Francoise","family":"Forette","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Padovani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Berthet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Knox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1007\/s12603-010-0267-7_bib1","unstructured":"Prevalence of dementia in Europe. Alzheimer Europe. Available at: http:\/\/www.alzheimer-europe.org\/Our-Research\/European-Collaboration-on-Dementia\/Prevalence-of-dementia2\/Prevalence-of-dementia-in-Europe. Accessed December 4, 2009."},{"issue":"9503","key":"10.1007\/s12603-010-0267-7_bib2","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1016\/S0140-6736(05)67889-0","article-title":"Global prevalence of dementia: a Delphi consensus study","volume":"366","author":"Ferri","year":"2005","journal-title":"Lancet"},{"issue":"7","key":"10.1007\/s12603-010-0267-7_bib3","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s12603-010-0269-5","article-title":"Physicians and caregivers: ready and waiting for increased participation in clinical research","volume":"14","author":"Jones","year":"2010","journal-title":"J Nutr Health Aging"},{"issue":"7","key":"10.1007\/s12603-010-0267-7_bib4","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/s12603-010-0268-6","article-title":"Screening for cognitive impairment, Alzheimer's disease and other dementias: opinions of European caregivers, payors, physicians and the general public","volume":"14","author":"Bond","year":"2010","journal-title":"J Nutr Health Aging"},{"issue":"1","key":"10.1007\/s12603-010-0267-7_bib5","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3233\/JAD-2009-1016","article-title":"Does cognitive impairment influence burden in caregivers of patients with Alzheimer's disease?","volume":"17","author":"Germain","year":"2009","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"10.1007\/s12603-010-0267-7_bib6","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1177\/0891988703252558","article-title":"Patients with Alzheimer's disease living at home in France: costs and consequences of the disease","volume":"16","author":"Rigaud","year":"2003","journal-title":"J Geriatr Psychiatry Neurol"},{"issue":"6","key":"10.1007\/s12603-010-0267-7_bib7","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1377\/hlthaff.17.6.206","article-title":"Alzheimer's disease care: costs and potential savings","volume":"17","author":"Leon","year":"1998","journal-title":"Health Aff (Millwood)"},{"issue":"1\u20132","key":"10.1007\/s12603-010-0267-7_bib8","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1159\/000074079","article-title":"Donepezil for the treatment of mild to moderate Alzheimer's disease in France: the economic implications","volume":"17","author":"Fagnani","year":"2004","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"7","key":"10.1007\/s12603-010-0267-7_bib9","doi-asserted-by":"crossref","first-page":"573","DOI":"10.2165\/00002512-200825070-00004","article-title":"Impact of rivastigmine on caregiver burden associated with Alzheimer's disease in both informal care and nursing home settings","volume":"25","author":"Grossberg","year":"2008","journal-title":"Drugs Aging"},{"issue":"2","key":"10.1007\/s12603-010-0267-7_bib10","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.amjopharm.2005.07.001","article-title":"Impact of donepezil use in routine clinical practice on health care costs in patients with Alzheimer's disease and related dementias enrolled in a large medicare managed care plan: a case-control study","volume":"3","author":"Lu","year":"2005","journal-title":"Am J Geriatr Pharmacother"},{"issue":"3","key":"10.1007\/s12603-010-0267-7_bib11","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/jnnp.72.3.310","article-title":"Cholinesterase inhibitor treatment alters the natural history of Alzheimer's disease","volume":"72","author":"Lopez","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"10.1007\/s12603-010-0267-7_bib12","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1136\/jnnp.2008.158964","article-title":"Long-term effects of the concomitant use of memantine with cholinesterase inhibition in Alzheimer disease","volume":"80","author":"Lopez","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"10.1007\/s12603-010-0267-7_bib13","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1159\/000105162","article-title":"Analysis of the effect of memantine in reducing the worsening of clinical symptoms in patients with moderate to severe Alzheimer's disease","volume":"24","author":"Wilkinson","year":"2007","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"3","key":"10.1007\/s12603-010-0267-7_bib14","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1159\/000241877","article-title":"Effectiveness of donepezil in reducing clinical worsening in patients with mild-to-moderate Alzheimer's disease","volume":"28","author":"Wilkinson","year":"2009","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1007\/s12603-010-0267-7_bib15","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1159\/000091790","article-title":"3-Year study of donepezil therapy in Alzheimer disease: effects of early and continuous therapy","volume":"21","author":"Winblad","year":"2006","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1007\/s12603-010-0267-7_bib16","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1001\/archneur.58.3.427","article-title":"Open-label, multicenter, phase 3 extension study of the safety and efficacy of donepezil in patients with Alzheimer disease","volume":"58","author":"Doody","year":"2001","journal-title":"Arch Neurol"},{"issue":"2","key":"10.1007\/s12603-010-0267-7_bib17","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1212\/01.WNL.0000129990.32253.7B","article-title":"The efficacy of donepezil in the treatment of neuropsychiatric symptoms in Alzheimer disease","volume":"63","author":"Holmes","year":"2004","journal-title":"Neurology"},{"issue":"5","key":"10.1007\/s12603-010-0267-7_bib18","first-page":"417","article-title":"Realistic expectations for treatment success in Alzheimer's disease","volume":"10","author":"Geldmacher","year":"2006","journal-title":"J Nutr Health Aging"},{"issue":"4","key":"10.1007\/s12603-010-0267-7_bib19","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1212\/WNL.57.4.613","article-title":"A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease","volume":"57","author":"Feldman","year":"2001","journal-title":"Neurology"},{"issue":"14","key":"10.1007\/s12603-010-0267-7_bib20","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1056\/NEJMoa013128","article-title":"Memantine in moderate-to-severe Alzheimer's disease","volume":"348","author":"Reisberg","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1007\/s12603-010-0267-7_bib21","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1185\/03007990903236731","article-title":"Donepezil treatment in severe Alzheimer's disease: a pooled analysis of three clinical trials","volume":"25","author":"Winblad","year":"2009","journal-title":"Curr Med Res Opin"}],"container-title":["The Journal of nutrition, health and aging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12603-010-0267-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12603-010-0267-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1279770723024806?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1279770723024806?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12603-010-0267-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T13:07:05Z","timestamp":1761138425000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1279770723024806"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":21,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S1279770723024806"],"URL":"https:\/\/doi.org\/10.1007\/s12603-010-0267-7","relation":{},"ISSN":["1279-7707"],"issn-type":[{"type":"print","value":"1279-7707"}],"subject":[],"published":{"date-parts":[[2010,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Implications of the impact survey for payors across Europe","name":"articletitle","label":"Article Title"},{"value":"The Journal of nutrition, health and aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s12603-010-0267-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2010 SERDI Publisher.","name":"copyright","label":"Copyright"}]}}